<DOC>
	<DOCNO>NCT01169259</DOCNO>
	<brief_summary>The VITamin D OmegA-3 TriaL ( VITAL ) ongoing randomize clinical trial 25,874 U.S. men woman investigate whether take daily dietary supplement vitamin D3 ( 2000 IU ) omega-3 fatty acid ( OmacorÂ® fish oil , 1 gram ) reduce risk develop cancer , heart disease , stroke people prior history illness .</brief_summary>
	<brief_title>Vitamin D Omega-3 Trial ( VITAL )</brief_title>
	<detailed_description>The VITamin D OmegA-3 TriaL ( VITAL ) ongoing randomize clinical trial vitamin D ( form vitamin D3 [ cholecalciferol ] ) marine omega-3 fatty acid ( eicosapentaenoic acid [ EPA ] + docosahexaenoic acid [ DHA ] ) supplement primary prevention cancer cardiovascular disease . Existing data laboratory study , epidemiologic research , small primary prevention trial , and/or large secondary prevention trial strongly suggest nutritional agent may reduce risk cancer cardiovascular disease , large primary prevention trial adequate dose general population lack . Eligible participant assign chance ( like coin toss ) one four group : ( 1 ) daily vitamin D3 omega-3 ; ( 2 ) daily vitamin D3 omega-3 placebo ; ( 3 ) daily vitamin D placebo omega-3 ; ( 4 ) daily vitamin D placebo omega-3 placebo . Participants equal chance assign four group 3 4 chance get least one active agent . Participants group take two pill day -- one softgel contain either vitamin D3 vitamin D placebo one capsule contain either omega-3 omega-3 placebo . Participants receive study pill convenient calendar package via U.S. mail . Participants also fill short ( 15-20 minute ) questionnaire year . The questionnaire ask health ; lifestyle habit physical exercise , diet , smoking ; use medication dietary supplement ; family history illness , new medical diagnosis . Occasionally , participant may receive phone call study staff collect information clarify responses questionnaire . At baseline , 16,956 VITAL participant provide optional blood sample . Approximately 6,000 participant provide follow-up blood sample year 1-4 trial . At baseline year 2 trial , subcohort 1,054 VITAL participant live within drive distance Boston , Massachusetts receive detailed in-clinic health assessment Clinical Translational Science Center ( CTSC ) Brigham Women 's Hospital . During CTSC visit , participant clinical exam , include measurement height , weight , anthropometrics , blood pressure , physical performance . They also provide fast blood urine sample , undergo 2-hour oral glucose tolerance testing , lung function test ( spirometry ) , electrocardiograms , bone mineral density testing , 2D-echocardiography , assessment think mood .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>To eligible study , respondent , study entry , : 1. men age 50 old woman age 55 old ; 2. history cancer ( except nonmelanoma skin cancer ) , heart attack , stroke , transient ischemic attack , angina pectoris , CABG , PCI ; 3. none follow safety exclusion : history renal failure dialysis , hypercalcemia , hypo hyperparathyroidism , severe liver disease ( cirrhosis ) , sarcoidosis granulomatous disease active chronic tuberculosis Wegener 's granulomatosis ; 4. allergy fish soy ; 5. serious illness would preclude participation ; 6. consume 800 IU vitamin D supplemental source combine ( individual vitamin D supplement , calcium+vitamin D supplement , medication vitamin D [ e.g. , Fosamax Plus D ] , multivitamin ) , , take , willing decrease forego use trial ; 7. consuming 1200 mg/d calcium supplemental source combine , , take , willing decrease forego use trial ; 8. take fish oil supplement , , take , willing forego use trial</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>vitamin D3</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>fish oil</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>cancer</keyword>
	<keyword>primary prevention</keyword>
</DOC>